HopeStage
Back to all studies
CompletedNCT03156335

Focused Ultrasound Capsulotomy for Treatment-Resistant OCD: A Safety Study

About this title

Trial of MR-guided Focused Ultrasound (MRgFUS) Bilateral Capsulotomy for the Treatment of Refractory Obsessive-compulsive Disorder (OCD)

Read the official source — NCT03156335
Device studyAges 20–80Canada
The study in practice

Understand this study

Who was this study for?

Listed age limits: 20 years to 80 years.

Listed locations
Calgary and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: April 20, 2017
Recruitment status
Completed
Enrollment listed in the registry
12
Sponsor
Sunnybrook Health Sciences Centre
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
Canada
Age range
From 20 Years to 80 Years
Official registry ID
NCT03156335
Official title
Show the full official title

Phase I Trial of MR-guided Focused Ultrasound (MRgFUS) Bilateral Capsulotomy for the Treatment of Refractory Obsessive-compulsive Disorder (OCD)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Calgary · Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Sunnybrook Health Sciences Centre.

Who was this study for?

Listed age limits: 20 years to 80 years.

Want to explore more studies?

Explore studies